1. Introduction {#sec1}
===============

Lectins are group of molecules which are highly specific for the binding of carbohydrate. It was earliest discovered in leguminous plants, therefore it was named legume lectin (or L-type lectin). Thereafter, many other members of lectins have been identified in most kinds of organisms, such as fungi, animals and plants. L-type lectins (LTLs) possess a luminal carbohydrate recognition domain which can bind to saccharides. In vertebrates, four kinds of LTLs have been reported, namely endoplasmic reticulum Golgi intermediate compartment-53 (ERGIC-53), ERGIC-53 like protein (ERGL), 36 kDa vesicular integral membrane protein (VIP36), and VIP36 like protein (VIPL) [@bib1]. However, only ERGIC-53 and VIP36 were identified in invertebrates [@bib2].

LTLs are associated with trafficking in the secretory pathway in endoplasmic reticulum Golgi by interaction with glycoproteins [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. For example, VIP36 locates in the Golgi and transfers between Golgi and endoplasmic reticulum (ER). It serves as the export receptor in ER and is associated with export of glycoprotein [@bib8]. VIP36 was involved in the regulation of the phagocytosis in macrophage [@bib9]. Similarly, *Mj*L-lectin promoted the hemocytes phagocytosis in kuruma shrimp (*Marsupenaeus japonicus*) [@bib10]. ERGIC-53 is a mannose-specific membrane lectin operating as a cargo receptor for the transport of glycoproteins from the ER to the ERGIC.

White spot syndrome virus (WSSV) is the type species of the genus *Whispovirus* in the family Nimaviridae. WSSV has caused great economic loss in shrimp aquaculture industry worldwide. Up to date, there is lack of effective strategies against WSSV infection. The studies of WSSV replication and host-interactions would help to explore effective strategies for WSSV prevention and control. There is growing evidence that ERGIC-53 is closely related with virus infection. ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles [@bib11]. In the present study, a LTL (named *Pc*L-lectin) was identified from red swamp crayfish, *Procambarus clarkii*. Gene sequencing and phylogenetic tree analysis results showed that the *Pc*L-lectin was a member of ERGIC-53. The expression level of *Pc*L-lectin was significantly down regulated in crayfish after challenged with white spot syndrome virus (WSSV). The anti-viral properties of the *Pc*L-lectin were further investigated by using recombinant *Pc*L-lectin protein as well as RNA interference (RNAi). Viral proteins which might interact with the *Pc*L-lectin were also studied. The results suggest that *Pc*L-lectin may play an important role in response to WSSV infection in red swamp crayfish.

2. Materials and methods {#sec2}
========================

2.1. Virus preparation {#sec2.1}
----------------------

The WSSV was isolated and kept in our laboratory. The WSSV was maintained and multiplied by infection in red swamp crayfish using the method described previously [@bib12]. One gram of the gill tissue from the infected crayfish was homogenized in 10 mL of phosphate-buffered saline (PBS, 140 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 2 mM KH~2~PO~4~, pH = 7.4). Thereafter, it was centrifuged at 10,000 rpm for 30 min at 4 °C. The supernatant was stored at −80 °C until use after filtration with 0.45 μm filter.

2.2. Red swamp crayfish challenged with WSSV and tissue collection {#sec2.2}
------------------------------------------------------------------

Red swamp crayfish (8--12 g) were purchased from the Baishazhou market in Wuhan city, Hubei Province, China. The crayfish were kept in an aerated water tank at room temperature (23 ± 2 °C), and changed fresh water every day. Hemocyte, heart, hepatopancreas, gill, stomach and intestine were collected from healthy red swamp crayfish (3 crayfish) for the studying the tissue distribution of *Pc*L-lectin. Total RNAs were extracted from these tissues by using RNAiso Plus (Takara, Dalian, China) according to the manufacturer's protocol. Reverse transcription was carried out using PrimeScript™ RT reagent Kit with gDNA Eraser (Takara, Dalian, China). The obtained cDNAs were stored at −20 °C. Meanwhile, total proteins were extracted from these samples, 100 μg tissues was homogenized in 1 mL RIPA buffer (Beyotime, Beijing, China), and then centrifuged at 10,000 rpm for 30 min at 4 °C. The supernatant was boiled with SDS loading buffer for 5 min, and stored at −20 °C until use.

The infection experiment was performed as described previously [@bib13]. Briefly, 25 μL of WSSV (about 1 × 10^7^ copies) or PBS (as the control) was injected into the abdominal segment of the red swamp crayfish (60 crayfish each group), respectively. Hemocytes were collected from red swamp crayfish for the expression pattern analysis of *PcL-lectin* at 0, 6, 12, 24 and 48 h post of WSSV challenge and dissolved in 1/2 hemocyte volume of anticoagulant buffer \[0.14 M NaCl, 0.1 M glucose, 30 mM trisodium citrate, 26 mM citric acid, and 10 mM ethylene diamine tetra acetic acid (EDTA), pH 4.6\] [@bib14]. The hemocytes were immediately centrifuged at 800 *g* for 8 min (4 °C). Thereafter, total RNAs and proteins were extracted as described above.

2.3. cDNA cloning and sequence analysis {#sec2.3}
---------------------------------------

Expressed sequence tag (EST) sequences similar to L-type lectin genes were obtained from transcriptomic sequencing of the heart of red swamp crayfish in our pilot experiments. The EST sequences were highly similar to the sequences of ERGIC-53 from Chinese mitten crab (*Eriocheir sinensis*) with around 86% amino acid sequence identity after BLAST analysis using the NCBI database (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). At the same time, the domain architecture of the *Pc*L-lectin was analyzed by SMART (<http://smart.embl-heidelberg.de/>).

2.4. Recombinant PcL-lectin protein expression, purification and antiserum preparation {#sec2.4}
--------------------------------------------------------------------------------------

The lectin leg-domain of *Pc*L-lectin gene was amplified from hemocytes using the Ex*Pc*L-lecF and Ex*Pc*L-lecR primers with *Eco*RI and *Xho*I restriction site ([Table 1](#tbl1){ref-type="table"} ). The PCR procedure was 1 cycle at 95 °C for 5 min; 35 cycles at 94 °C for 30 s, 56 °C for 45 s, and 72 °C for 1 min; and 1 cycle at 72 °C for 10 min. PCR products were examined by 1.0% agarose gel electrophoresis. Then, the amplified DNA fragments were purified with gel extraction kit (Aidlab, Beijing, China). Both DNA fragments and the vector pGEX-KG were digested with the corresponding DNA restriction endonuclease at 37 °C for 1 h, and ligated in water bath overnight at 16 °C using T4 ligase (Fermentas, USA). The recombinant plasmids pGEX-KG-L-lectin was transformed into *Eriocheir coli* BL21 (DE3) cells, isopropyl-b-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG) was used to induce the expression of the recombinant *Pc*L-lectin (r*Pc*L-lectin). Thereafter, it was purified from the inclusion body of the *E. coli* BL21. Specific polyclonal antibody of *Pc*L-lectin was obtained by immunizing rabbit with the purified recombinant protein.Table 1Sequences of the primers used in this study.PrimersSequence (5′--3′)ExPcL-lecFTACTCAGAATTCCGTACCTGGCGCAGAAGGExPcL-lecRTACTCACTCGAGTTACTTTCTGTACAGCATCRT-PcL-lecFCTTGGTGGCTGCCTTAGAGRT-PcL-lecRTCCTTCTCATTGTTTGTCATTC18S FTCTTCTTAGAGGGATTAGCGG18S RAAGGGGATTGAACGGGTTARNAi-PcL-lecFGCGTAATACGACTCACTATAGGTTGAGATTGTTGCAAATGCRNAi-PcL-lecRGCGTAATACGACTCACTATAGGGCTAAAATATAAACCTACCRNAi-GFP-FGCGTAATACGACTCACTATAGGTGGTCCCAATTCTCGTGGAACRNAi-GFP-RGCGTAATACGACTCACTATAGGCTTGAAGTTGACTTGATGCC

2.5. Immune-fluorescent assay of PcL-lectin in hemocytes {#sec2.5}
--------------------------------------------------------

Hemocytes were collected as above and Immune-fluorescent assay was performed to determine the location of *Pc*L-lectin in the hemocytes as described previously [@bib15].

2.6. Tissue distribution and expression profiles of PcL-lectin detected by quantitative real-time PCR (qRT-PCR) and Western blot {#sec2.6}
--------------------------------------------------------------------------------------------------------------------------------

The tissue distributions and expression profiles of *PcL-lectin* were analyzed using qRT-PCR with the *Pc*L-lectin specific primers RT-*Pc*L-lecF and RT-*Pc*L-lecR ([Table 1](#tbl1){ref-type="table"}). The 18S rRNA was used as the reference and was amplified with the primers 18S F and 18SR ([Table 1](#tbl1){ref-type="table"}). The qRT-PCR was programmed at 95 °C for 10 min, followed by 40 cycles at 95 °C for 10 s, 60 °C for 1 min. DNA melting analysis was performed to confirm the specificity of the amplified products. The obtained data were statistically analyzed and calculated using the threshold cycle method as previously described [@bib16].

Meanwhile, the tissue distribution and expression profiles of the *Pc*L-lectin protein were measured by Western blot using antiserum of *Pc*L-lectin as described previously [@bib13].

2.7. Recombinant PcL-lectin protein (rPcL-lectin) and the replication of WSSV {#sec2.7}
-----------------------------------------------------------------------------

To analyze the relationship between *Pc*L-lectin and the replication of WSSV, we performed following experiments in four groups of crayfish (5 crayfish each group). Group 1 (control): red swamp crayfish were injected with 50 μL PBS. Group 2 (PBS + WSSV): injected with 50 μL PBS containing WSSV (1 × 10^5^ virions). Group 3 (GST + WSSV): injected with 50 μL mixture containing 200 μg GST protein and WSSV (1 × 10^5^ virions). Group 4 (r*Pc*L-lectin + WSSV): injected with 50 μL mixture containing 200 μg of r*Pc*L-lectin and WSSV (1 × 10^5^ virions). At 60 h post of challenge, the genomic DNA from gills of the treated red swamp crayfish were extracted using a genomic DNA extraction kit (CWbio, Beijing, China), qPCR was used to quantify the copy of WSSV genome in the crayfish with the *vp28* primers RT-vp28F/R as described previously [@bib17]. Meanwhile, proteins were extracted from the gills, and Western blot was performed using antiserum of VP28 as described previously [@bib17].

2.8. RNA interference (RNAi) assay {#sec2.8}
----------------------------------

Gene-specific primers for *PcL-lectin* (RNAi-*PcL-lec*F/R) and green fluorescent protein (*GFP*, RNAi-*GFP*-F/R) were incorporated with the T7 promoter showed in [Table 1](#tbl1){ref-type="table"}. T7 polymerase (Fermentas, USA) was used to synthesize dsRNA based on the method as described [@bib18]. Crayfish were randomly divided into four groups (8 crayfish each group). The group 1 (control): without any treatment. The group 2 (PBS): each red swamp crayfish was injected with 25 μL PBS. The group 3 (*dsGFP*): injected with 25 μL *dsGFP* RNA. The group 4 (*dsPcL-lectin*): injected with 25 μL *dsPcL-lectin* RNA. At 48 h post of the treatment, total RNAs and proteins were extracted from the gills of the red swamp crayfish as mentioned above. qPCR and Western blotting were used to detect the efficiency of the RNAi. β-actin was used as control in western blot.

Infected experiment with WSSV after knock down of *Pc*L-lectin was carried out. Crayfish were divided into four groups. The group 1 (normal): no treatment. The group 2 (*dsPcL-lectin* + WSSV): each crayfish was first injected with *dsPcL-lectin* RNA, 48 h later after the first injection, WSSV (1 × 10^5^ virions) was injected. The group 3 (*dsGFP* + WSSV): first injected with *dsGFP* RNA, 48 h later, injected with WSSV (1 × 10^5^ virions). The group 4 (PBS + WSSV): first injected with PBS, 48 h later, injected with WSSV (1 × 10^5^ virions). At 60 h post of WSSV challenged, total proteins were extracted from the gills of the crayfish, and the expression of VP28 of WSSV was detected by Western blot.

2.9. Rescue assay with rPcL-lectin after RNAi treatment {#sec2.9}
-------------------------------------------------------

The crayfish were divided into five groups and performed the following experiments (3 crayfish each group). The group 1 (PBS + WSSV): first injected nothing, after 48 h, PBS was injected, waited for 1 h, WSSV (1 × 10^5^visions) was injected. The group 2 (*dsPcL-lectin* + r*Pc*L-lectin + WSSV): first injected *dsPcL-lectin*, after 48 h, r*Pc*L-lectin was injected, waited for 1 h, WSSV (1 × 10^5^virions) was injected. The group 3 (*dsPcL-lectin* + GST + WSSV): first injected with *dsPcL-lectin*, after 48 h, GST was injected, waited for 1 h, then WSSV (1 × 10^5^virions) was injected. The group 4 (*dsGFP* + GST + WSSV): first injected with *dsGFP*, after 48 h, GST was injected, waited for 1 h, then WSSV (1 × 10^5^virions) was injected. The group 5 (*dsGFP* + r*Pc*L-lectin + WSSV): first injected with *dsGFP*, after 48 h, r*Pc*L-lectin was injected, waited for 1 h, WSSV (1 × 10^5^virions) was injected. At 60 h after WSSV challenged, protein samples were extracted from the gills, and the amount of WSSV was revealed by Western blot using anti-VP28 antibody.

2.10. Pull-down and co-IP assays {#sec2.10}
--------------------------------

To confirm the interaction of *Pc*L-lectin with viral proteins, pull-down assays was performed using GST-tag fused *Pc*L-lectin (GST-*Pc*L-lectin) and His-tag fused viral proteins (His-VP15, His-VP19, His-VP24, His-VP26 and His-VP28). All these His-tag fused WSSV proteins were purified from *E. coli* which transformed pET-32 are combinant plasmids containing above viral genes. GST bind resin was used in this assay, and the pull-down was carried out as described previously [@bib13]. Approximately 200 μg of purified GST-*Pc*L-lectin was incubated with GST bind resin (GenScript, Nanjing, China) for 1 h, washed with PBS. About 400 μg of purified His-VP15 (His-VP19, His-VP24, His-VP26 or His-VP28) was added to the resin and incubated at 4 °C for 2 h. After being washed thoroughly with PBS, the proteins were eluted with elution buffer (GenScript, Nanjing, China) and then analyzed by 12% SDS-PAGE. GST bound resin was used as control, followed by washing with PBS and eluted with elution buffer.

To further analyze interaction of *Pc*L-lectin with VP24, Co-IP assay was performed using antiserums of *Pc*L-lectin and VP24 (VP24 antiserum was a gift of professor Jin-Xing Wang, Shandong University). A tube with antiserum-free protein A resin was used for control. The Co-IP assay was carried out as described previously [@bib19]. Samples from crayfish gills challenged with WSSV were collected, and then were incubated with antiserum of *Pc*L-lectin or VP24 overnight at 4 °C with rotation. The suspension was then incubated with 10 μL of Protein A beads for1 h at 4 °C under agitation. The beads were collected and washed 4 times, then were resuspended in 30 μL of SDS-PAGE sample buffer and boiled for10 min. The samples were analyzed by Western blot.

3. Results {#sec3}
==========

3.1. Sequence characteristics of PcL-lectin {#sec3.1}
-------------------------------------------

The obtained *PcL-lectin* sequence was 1680 bp with 1506 bp open reading frame (ORF) encoding a 501 amino acid protein with a predicted molecular weight of 56.8 kDa ([Fig. S1](#appsec1){ref-type="sec"}). SMART analysis showed that the *Pc*L-lectin contained a putative signal peptide of 19 amino acids, one lectin leg-like domain located at the N-terminal and one transmembrane domain at the C-terminal, one coiled coil region and one low complexity region in the middle ([Fig. 4](#fig4){ref-type="fig"}B). After BLAST in NCBI, the *Pc*L-lectin was most related to ERGIC-53 members. Therefore, ERGIC-53 from other nine species were included to construct a phylogenetic tree. These species were common periwinkle (*Littorina littorea*), oyster (*Crassostrea gigas*), Chinese mitten crab (*Eriocheir sinensis*), fly (*Drosophila melanogaster*), large yellow croaker (*Larimichthys crocea*), frog (*Xenopus tropicalis*), green sea turtle (*Chelonia mydas*), woodpecker (*Picoides pubescens*), and human (*Homo sapiens*). The results showed that *PcL-lectin* was most similar with the Chinese mitten crab *Es*ERGIC-53 with 86% amino acid identity ([Fig. S2](#appsec1){ref-type="sec"}).

3.2. The location of PcL-lectin in the hemocytes of crayfish {#sec3.2}
------------------------------------------------------------

To monitor the location of the *Pc*L-lectin, the lectin leg-like domain (around 28 kDa) fused to GST to generate a recombinant *Pc*L-lectin with molecular weight of about 54 kDa was used as antigen to generate rabbit anti-serum of *Pc*L-lectin ([Fig. 1](#fig1){ref-type="fig"} ). A specific band about 57 kDa which was identical the molecular weight of *Pc*L-lectin was detected from the hemocytes of crayfish, indicating that the anti-serum could be used to detect the native *Pc*L-lectin ([Fig. 1](#fig1){ref-type="fig"}). Immune-fluorescent assay was used to investigate the cellular localization of *Pc*L-lectin in the hemocytes from non-infected crayfish. The results showed that *Pc*L-lectin was mainly distributed on the membrane and the cytoplasm of hemocytes, which is identical with the existed of the predicted transmembrane domain of the *Pc*L-lectin ([Fig. 4](#fig4){ref-type="fig"}).Fig. 1SDS--PAGE analysis of recombinant r*Pc*L-lectin protein and the specificity of its anti-serum. pGEX-Llec-DE3 represents control group, rPcL-lectin protein was not expressed without IPTG induction. pGEX-Llec-DE3+IPTG represents experiment group, r*Pc*L-lectin protein was expressed in *E. coli* with IPTG induction. GST-L-lec represents purified r*Pc*L-lectin protein from *E. coli*, L-lec represents *Pc*L-lectin, antiserum could recognize endogenous L-lectin from the crayfish.

3.3. Tissue distribution and expression profiles of PcL-lectin {#sec3.3}
--------------------------------------------------------------

The mRNA expressions of *PcL-lectin* from the tissues of hemocyte, heart, hepatopancreas, gill, stomach and intestine of crayfish were measured by qRT-PCR. The results showed that the mRNA of *PcL-lectin* was expressed in all tested tissues, with higher expression levels in the hemocytes, heart and stomach, and lower expression levels in hepatopancreas, gills and intestine ([Fig. 2](#fig2){ref-type="fig"} A). Furthermore, the extracted proteins from the above six tissues were subjected to Western blot assay. The results showed that the expression patterns of *Pc*L-lectin at both mRNA and protein levels were similar in the six tissues ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Tissues distribution of *Pc*L-lectin. (A) The expressions of *Pc*L-lectin mRNA in the six tissues of crayfish. The extracted total mRNAs from hemocytes, heart, hepatopancreas, gills, stomach and intestine were subjected to qRT-PCR assay. The 18S rRNA was used as reference. (B) The expression of *Pc*L-lectin protein in the six tissues of crayfish. The extracted total proteins from the six tissues were subjected to Western blot assay. β-actin was used as internal control. The experiments were repeated three times. Different letters represented significant changes between groups, p \< 0.05.

3.4. The effects of PcL-lectin on the multiplication of WSSV {#sec3.4}
------------------------------------------------------------

Hemocyte was the major site for the multiplication of WSSV, therefore, we investigated the expression profiles of *Pc*L-lectin in hemocytes from the swamp crayfish challenged with WSSV. The results showed that the overall mRNA of *PcL-lectin* was declined in hemocytes at 12 and 48 h post of challenge ([Fig. 3](#fig3){ref-type="fig"} A). The overall expression profiles of *Pc*L-lectin protein was similar with those of *PcL-lectin* mRNA, with a slight enhancement at 48 h post of challenge ([Fig. 3](#fig3){ref-type="fig"}B). These results showed that WSSV challenge was able to down-regulate the expression of *Pc*L-lectin. To determine whether the *Pc*L-lectin has an effect on the WSSV multiplication, the recombinant GST-fused *Pc*L-lectin (r*Pc*L-lectin) was injected into crayfish. Thereafter, the crayfish were challenged with WSSV. qRT-PCR and Western blot were performed to detect the multiplication of WSSV in gills. The results showed that the viral specific mRNA and protein in the r*Pc*L-lectin injection group were markedly higher than those in the control groups (GST-WSSV, PBS-WSSV and WSSV) only ([Fig. 5](#fig5){ref-type="fig"} A,B), indicating that *Pc*L-lectin could facilitate the multiplication of WSSV.Fig. 3Expression pattern of *Pc*L-lectin. The expression pattern of *Pc*L-lectin was detected by qRT-PCR and Western blot assays after challenged with WSSV. (A) Expression pattern analysis of the *Pc*L-lectin expression pattern in the hemocytes of the WSSV-challenged crayfish at 0, 6, 12, 24 and 48 h post of the challenge. (B) Western blot was used to detect the expression pattern of *Pc*L-lectin. Each experiment was repeated three times. Different letters represented significant changes between groups, p \< 0.05.Fig. 4Immune-fluorescent assay of *Pc*L-lectin in hemocytes. (A)Hemocytes were analyzed by immune-fluorescent assay using anti *Pc*-Lectin rabbit serum or serum (pre-serum) from rabbit without treated with any antigen. Nuclear was stained with DAPI. The green showed signal of *Pc*L-lectin, the blue showed signal of nuclear. Merge showed the location of *Pc*L-lectin and nuclear. (B) Domain structure of *Pc*L-lectin, red showed signal peptide, grey showed lectin leg-like domain, green showed coiled-coil structure, purple showed low complexity structure, blue showed transmembrane domain. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 5Recombinant *Pc*L-lectin protein and WSSV replication. Crayfish was divided into four groups. Group 1 was control, Group 2 was injected with PBS and WSSV, Group 3 was injected with GST-tag and WSSV, Group 4 was injected with GST-*Pc*L-lectin and WSSV. (A) Genome DNA was extracted from Gills, and qPCR was used to detect the amount of WSSV (vp28 mRNA as the marker for WSSV replication). (B)Total protein was extracted from gills of crayfish, and western blot was used to detect the amount of WSSV (VP28 as a marker for WSSV). Each experiment was repeated three times. Different letters represented significant changes between groups, p \< 0.05.

To further address the relationship between *Pc*L-lectin and WSSV multiplication, we performed *Pc*L-lectin knock-down and rescue experiments. Both mRNA and protein of *Pc*L-lectin could be significantly knocked down by the injection of *Pc*L-lectin specific dsRNA into the crayfish ([Fig. 6](#fig6){ref-type="fig"} A,B). The multiplication of WSSV was inhibited in the crayfish which *Pc*L-lectin has been knocked down ([Fig. 6](#fig6){ref-type="fig"}C). However, the inhibition could be rescued when recombinant *Pc*L-lectin protein was injected into the crayfish which native *Pc*L-lectin has been knocked down by RNAi. But the rescue was not observed in the crayfish which were treated with control RNAi (GFP RNAi) and injected with control protein (GST) ([Fig. 6](#fig6){ref-type="fig"}D), indicating that *Pc*L-lectin may play a role in the multiplication of WSSV in crayfish.Fig. 6*Pc*L-lectin knockdown inhibited WSSV in crayfish. The crayfish were subjected to RNA interference with *dsGFP* as the control. (A and B) Effect of *Pc*L-lectin RNAi on gills determined using qPCR and Western blot analysis. (C)The crayfish were infected with WSSV after *Pc*L-lectin knockdown, and the amount of WSSV was detected via western blot using VP28 as a marker. (D)The rescue experiment was also performed through the injection of r*Pc*L-lectin into the *PcL-lectin*-silenced and *GFP*-silenced crayfish; GST-tag was injected into the *PcL-lectin*-silenced and *GFP*-silenced crayfish as controls. Different letters represented significant changes between groups, p \< 0.05.

3.5. PcL-lectin bound to WSSV structural protein VP24 {#sec3.5}
-----------------------------------------------------

The above results suggested that *Pc*L-lectin may affect the multiplication of WSSV, but its mechanism remains unclear. One possibility was that *Pc*L-lectin might directly interact with the viral protein, so as to regulate the multiplication of WSSV. Therefore, the interaction of *Pc*L-lectin with WSSV proteins was measured. Six His-tag fused proteins of WSSV (VP15, VP19, VP24, VP26 and VP28) were used in pull-down experiment with GST-tag fused *Pc*L-lectin *in vitro*. The results showed that only the VP24 could bind to r*Pc*L-lectin ([Fig. 7](#fig7){ref-type="fig"} A). A Co-IP assay was also performed using the lysate of the gills from WSSV-challenged crayfish. The results showed that native *Pc*L-lectin was able bind to VP24 ([Fig. 7](#fig7){ref-type="fig"}B). These results suggest that *Pc*L-lectin might physically interact with VP24.Fig. 7*Pc*L-lectin interacts with VP24 of WSSV. (A) *In vitro* pull-down assays were performed to detect the interactions of His-tag fused VP15, VP19, VP24, VP26, and VP28 with GST-PcL-lectin. A tube with GST resin was used as the control. (B)The Co-IP assay was performed using lysates of gills from WSSV-challenged crayfish, *Pc*L-lectin antiserum and VP24 antiserum. A tube with antiserum-free protein A resin was used as the control.

4. Discussion {#sec4}
=============

ERGIC-53 is a kind of lectin which mainly locates in ER and Golgi of cells [@bib20], [@bib21], [@bib22], [@bib23], and serves as a regulator of export of glycoproteins [@bib3], [@bib8]. In the present study, we cloned and characterized a novel ERGIC-53 (named *Pc*L-lectin) from red swamp crayfish. The *Pc*L-lectin was ubiquitously expressed in all six detected tissues of the crayfish ([Fig. 2](#fig2){ref-type="fig"}). The *Pc*L-lectin was ubiquitously expressed in all six detected tissues of the crayfish and located at the cytoplasm and membrane of hemocytes, which was identical to the existing of transmembrane domain of the *Pc*L-lectin.

There is growing evidence that the members of lectin family have been involved in virus infection. LdlrLec1 and LdlrLec1 interacted with VP28, and inhibited the infection and replication of WSSV in *M. japonicus* [@bib24]. *Mj*svCL, DC-SIGN and L-SIGN were served as receptor candidates in the infection of WSSV or influenza A virus [@bib25], [@bib26]. Lavvy, a kind of CTLs, was response to WSSV infection in *Litopenaeus vannamei*. *Mj*svCL together with calreticulin, was identified as a receptor in the infection of WSSV in *M. japonicus* [@bib25]. However, all these lectins identified from shrimps are all C-type lectins. It has been reported that ERGIC-53 was related with the replication of some RNA viruses, such as arenavirus, coronavirus, and filovirus [@bib11]. To better understand the function of *Pc*L-lectin in crayfish during WSSV infection, recombinant *Pc*L-lectin was further used for the studies. The results showed that recombinant *Pc*L-lectin was able to enhance the multiplication of WSSV in crayfish ([Fig. 5](#fig5){ref-type="fig"}) and it could rescues the multiplication of WSSV in the crayfish which their endogenous *Pc*L-lectin was knocked down by RNAi ([Fig. 6](#fig6){ref-type="fig"}), suggesting that *Pc*L-lectin may play a role in the multiplication of WSSV. The *Pc*L-lectin was down regulated in crayfish infected with WSSV at the early stage ([Fig. 3](#fig3){ref-type="fig"}), and recombinant *Pc*L-lectin protein could facilitate WSSV replication ([Fig. 5](#fig5){ref-type="fig"}). The mortality of the crayfish was enhanced 2 d post of the challenge with WSSV [@bib13]. It suggested that WSSV may utilize the *Pc*L-lectin which stored in cell at the early stage of infection. On the other hand, crayfish may also resist WSSV infection by down regulated the expression of *Pc*L-lectin. The reduction of *Pc*L-lectin could not completely suppress the replication of WSSV.

Virus structural proteins play an essential role in virus infection [@bib27]. It has been reported that WSSV envelope protein VP28 interacted with host protein and helped it entry into the host cell [@bib28], VP26 and VP24 were first identified as nuclear proteins and then they were found at envelope of WSSV [@bib29], [@bib30], VP24 together with VP28 could participate in the infection of WSSV [@bib31]. In this study, we showed that *Pc*L-Lectin interacted with VP24, but not VP28, VP26 ([Fig. 7](#fig7){ref-type="fig"}A and B). The exact mechanism underlying *Pc*L-lectin-VP24 interaction remains enigmatic and remains to be deciphered in the future.
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